Stay updated on Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.

Latest updates to the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has been updated to include new drug information and a revision number, while significant details about the study's purpose and inclusion/exclusion criteria have been removed.SummaryDifference11%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact for assistance.SummaryDifference0.5%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.